Funder
Asturpharma S.A. Consejería de Educación y Cultura del Principado de Asturias Banco de Santander-Universidad de Oviedo Oviedo
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference25 articles.
1. Sensi P, Margalith P, Timbal M. Rifomycin, a new antibiotic; preliminary report. Farmaco Ed Sci. 1959;14:146.
2. Riva S, Silvestri LG. Rifamycins: a general view. Annu Rev Microbiol. 1972;26:199.
3. Lounis N, Rosceigno G. In vitro and in vivo activities of new rifamycin derivatives against mycobacterial infections. Curr Pharm Des. 2004;10:3229.
4. Floss HG, Yu TW. Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev. 2005;105:621.
5. Prelog V, Oppolzer W. Ansamycins, a novel class of microbial metabolites. Helv Chim Acta. 1973;56:2279.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献